Burcon Nutrascience Corporation BU.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 272.83% | 1,921.14% | 1,107.74% | 773.06% | 43.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 272.83% | 1,921.14% | 1,107.74% | 773.06% | 43.03% |
| Cost of Revenue | 80.64% | 515.79% | 714.81% | 1,202.98% | 777.05% |
| Gross Profit | -37.93% | -406.61% | -607.99% | -1,348.63% | -6,352.81% |
| SG&A Expenses | 11.50% | -11.04% | -21.32% | -17.29% | -38.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.87% | 119.38% | 84.46% | 43.82% | 39.35% |
| Operating Income | -27.02% | -79.68% | -49.37% | -30.40% | -38.86% |
| Income Before Tax | -14.58% | -84.97% | -101.25% | -51.09% | -83.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.62% | -66.90% | -101.25% | -51.09% | -83.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.62% | -66.90% | -101.25% | -51.09% | -83.86% |
| EBIT | -27.02% | -79.68% | -49.37% | -30.40% | -38.86% |
| EBITDA | -- | -80.68% | -52.23% | -32.33% | -20.76% |
| EPS Basic | -8.59% | -30.57% | -13.09% | 15.36% | -2.96% |
| Normalized Basic EPS | -14.55% | -44.79% | -13.07% | 15.35% | -2.91% |
| EPS Diluted | -9.44% | -30.19% | -13.09% | 15.36% | -2.96% |
| Normalized Diluted EPS | -14.55% | -44.79% | -13.07% | 15.35% | -2.91% |
| Average Basic Shares Outstanding | 0.03% | 27.77% | 77.94% | 78.49% | 78.59% |
| Average Diluted Shares Outstanding | 0.03% | 27.77% | 77.94% | 78.49% | 78.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |